Influx Healthtech shareholders and shareholding pattern
NSE: INFLUXPharmaceuticals & Biotechnology
Influx Healthtech Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2025 · Issue price ₹96
Last close ₹270.05up ₹16.20 (6.38%)
Share price at the NSE close on 28 Oct 2026. Previous close ₹253.85.
28 Oct: open ₹259.95, high ₹274.95, low ₹259.05
52-week range of traded prices to 28 Oct 2026
₹169.00Low, 30 Oct 2025₹315.00High, 6 Jul 2026
- Next results date: the board meets on 4 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹625 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 30.41
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed. Price to book: how it is worked out
- 6.20
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record.
- 20.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. Taken from the consolidated balance sheet, the company and its subsidiaries together; the P/E is on the company's own results until four consolidated quarters are filed.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 25,20095.2% delivered
Influx Healthtech's shareholding pattern for Sep 2026, filed on 17 Oct 2026, with every filing from Sep 2025: who owns its shares by group, its promoters by name and its public holders of 1% or more.
Who owns Influx Healthtech, filing by filing
Per cent of the company's shares.
Sep 2026 filing
- Promoters73.53%
- Foreign institutions0.41%
- Indian institutions7.33%
- Individuals and others18.72%
Shareholding pattern, per cent
- Promoters
- Foreign institutions
- Indian institutions
- Individuals and others
| Per cent | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
| 73.53% | 73.53% | 73.53% | |
| Indian promoters | 73.53% | 73.53% | 73.53% |
| Public. Every shareholder outside the promoter group, the employee trusts and the shares held against depositary receipts, as the filing totals them. Public in the glossary | 26.47% | 26.47% | 26.47% |
| Shares in issue | 2,31,50,400 | 2,31,50,400 | 2,31,50,400 |
| Shares locked inShares locked in. Shares the filing reports as barred from sale until a set day, such as promoters' shares after a public issue or shares allotted to an investor directly. Shares locked in in the glossary | 1,70,49,600 | 1,70,49,600 | 46,30,800 |
| Promoters' shares locked in | 1,70,23,464 | 1,70,23,464 | 46,30,800 |
A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.
Influx Healthtech promoters
Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is MUNIR ABDUL GANEE CHANDNIWALA, 69.73%. The filing names 17 more members with no shares.
| Holder | |||
|---|---|---|---|
| MUNIR ABDUL GANEE CHANDNIWALAIndividuals and Hindu undivided families | 69.73% | 1,61,42,100 | 28.69% |
| SHIRIN MUNIR AHMED CHANDNIWALAIndividuals and Hindu undivided families | 3.80% | 8,80,638 | 0.00% |
| ABDUL GANEE ABDUL RASUL CHANDNIWALAIndividuals and Hindu undivided families | 0.00% | 726 | 0.00% |
No promoter shares are reported as pledged. Locked in is the share of the holder's own shares that cannot be sold yet, as after a listing or an allotment.
Largest public holders of Influx Healthtech, filing by filing
Per cent, on the same shares as the split above.
| Holder | Sep 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|
| SOLIDARITY MICRO CAP EMERGING LEADER AIFAlternative investment funds | – | – | 1.76% |
| KULBHUSHAN PARASHARResident individuals, over ₹2 lakh at face value | – | 1.87% | 1.73% |
| CCV EMERGING OPPORTUNITIES FUND-IAlternative investment funds | 2.31% | 1.85% | 1.37% |
| AARTH AIF GROWTH FUNDAlternative investment funds | 1.78% | 1.40% | 1.04% |
| FINAVENUE CAPITAL TRUST - FINAVENUE GROWTH FUNDAlternative investment funds | 1.37% | 1.35% | – |
| ROHAN GUPTAResident individuals, over ₹2 lakh at face value | 1.30% | – | – |
A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. A dash is a filing that did not name the holder, which includes holding under one per cent.
Who moved in the Sep 2026 filing
Against the Mar 2026 filing. A filing names a public holder only at 1% or more, so a holder no longer named fell under 1% or sold out.
- Indian institutions: SOLIDARITY MICRO CAP EMERGING LEADER AIF newly named at 1.76%; FINAVENUE CAPITAL TRUST - FINAVENUE GROWTH FUND no longer named, from 1.35%; CCV EMERGING OPPORTUNITIES FUND-I 1.37%, −0.48 pts; 1 more moved
- Individuals and others: KULBHUSHAN PARASHAR 1.73%, −0.14 pts